A Case-control Study of HIV Infection Among Incarcerated Female Drug Users: Impact of Sharing Needles and Having Drug-using Sexual Partners  by Peng, Eugene Yu-Chang et al.
446 J Formos Med Assoc | 2011 • Vol 110 • No 7
Contents lists available at ScienceDirect
Journal of the Formosan Medical Association
Journal homepage: http://www.jfma-online.com
J Formos Med Assoc 2011;110(7):446–453
Journal of the 
Formosan Medical Association
ISSN 0929 6646
Formosan Medical Association
Taipei, Taiwan
Volume 110 Number 7 July 2011
Enterovirus 71 vaccine: When will it be available?
GRP78 in embryonic development and neurological disorders
Directly observed therapy for Tuberculosis patients in Taiwan
HIV infection among incarcerated female drug users
Original Article
A Case-control Study of HIV Infection Among
Incarcerated Female Drug Users: Impact of Sharing
Needles and Having Drug-using Sexual Partners
Eugene Yu-Chang Peng,1,2 Ching-Ying Yeh,2 Shu-Hsing Cheng,2,3 Donald E. Morisky,4
Yu-Ching Lan,5 Yi-Ming Arthur Chen,6 Shu-Yu Lyu,2,6* Robert M. Malow7
Background/Purpose: Taiwan experienced a rapid surge in human immunodeficiency virus (HIV) among
injection drug users (IDUs) from 2003 to 2005. The male-to-female ratio of HIV cases decreased from
20:1 in 2003 to 6:1 in 2006. This change is primarily due to increasing numbers of female injection drug
users in Taiwan. Our primary objective was to identify the risk factors associated with HIV infection
among incarcerated female drug users.
Methods: A case-control design involved recruitment of all eligible HIV-infected female inmates from all
24 prisons in Taiwan from November to December, 2007. Eligible HIV seronegative controls were chosen
within the same prison and matched to the cases by age (within 3 years) and by history of illicit drug use.
A subsample of these matches was randomly selected since there were many more eligible controls than
HIV-infected cases. An anonymous self-administered questionnaire was completed with assistance from
trained research assistants.
Results: A total of 114 cases and 149 control participants were recruited, with a response rate of 82% and
54%. Injectable heroin use was significantly greater (p = 0.02) among HIV-infected cases (93.0%) than un-
infected controls (84.6%). Compared to seronegative controls, HIV-infected cases were more likely to share
drug paraphernalia and have drug-using sexual partners. Multiple logistic regression analysis revealed that
the number of imprisonments (between 2–5 times; OR = 5.23), sharing mainly dilutes (OR = 63.47), and
sharing dilutes concurrently with needles (OR = 127.33) significantly predicted HIV seroconversion, after
controlling for age and years of education.
Conclusion: Sharing needles/dilutes and practicing unsafe intercourse with drug-using sexual partners
places female drug users at considerable risk.
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Epidemiological trends are alarming among in-
carcerated women, who are 15 times more likely
to be human immunodeficiency virus positive
(HIV+) than non-incarcerated women.1 This is
particularly true in Taiwan, which experienced a
rapid rise in HIV infection among injection drug
users (IDUs) from 2003 to 2005.2 The proportion
of newly diagnosed HIV-infected cases attributed
to IDUs dramatically increased from 2.5% in 2002
to 8.9% in 2003, and to 70.3% in 2005.2,3
Boerma and Weir4 presented a proximate-
determinants framework, i.e. identification of a set
of variables, to study HIV infection by combining
demographic and epidemiological approaches.
Bingenheimer and Geronimus5 proposed three
categories of proximate determinants—behav-
ioral mechanisms, biological mechanisms, and
demographic and biomedical factors—as a con-
ceptual framework to guide HIV epidemiological
research. Female incarcerated populations include
large proportions of IDUs, who are at high risk
of contracting or transmitting HIV. Their HIV in-
fection risk is the result of biological factors,6–8
demographic factors,9,10 and behavioral and social
factors.11–15
Women are more likely than men to acquire
HIV from injecting drugs and heterosexual trans-
mission.16 Demographic factors, e.g. low educa-
tional attainment and limited condom use,
enhance women’s vulnerability to HIV.9,10 In ad-
dition to biological factors that enhance the risk
of women contracting HIV,6–8 social and cultural
factors may play a pivotal role.17 Srirak et al11
found that history of incarceration, history of in-
jection drug, experiencing sexual abuse, and trad-
ing sex for money were related to HIV among
female drug users in northern Thailand. Female
IDUs reported more commercial sex than males,
which might place them at higher HIV risk.14
Gender influences injection practices in regular
heterosexual relationships; male IDUs reported
more frequent injections, and were more likely
to inject their partners.15 HIV-infected female in-
mates tend to share injection paraphernalia more
frequently, and had more drug-using family mem-
bers or sexual partners.12 A recent study indicates
that half of female IDUs had a regular IDU sex
partner.13
Notably, the male-to-female ratio of HIV-
infected cases in Taiwan decreased from 20:1 
in 2003 to 6:1 in 2006. This is primarily due to
an increase in the number of female injection
drug users.3 However, little data is available on
Taiwanese female HIV-infected inmates. A previ-
ous Taiwanese study indicates higher HIV preva-
lence among incarcerated drug-using inmates in
males (11.6%) than females (8.6%).18
Incarcerated female drug users are at higher risk
for heterosexual transmission of HIV infection than
their non-incarcerated counterparts are. Sharing
needles and dilutes or having unprotected sex were
the most influential risk factors for HIV infection
in female drug users.11 In Taiwan, the situation of
incarcerated female drug users is not documented
well, as it is for males (e.g. Peng et al19).
Incarceration is often linked to HIV transmis-
sion,20 particularly with IDUs,21 but research has
yet to document whether this is applicable for
Taiwan. At this critical junction in the outbreak
of HIV among IDUs in Taiwan, it is important to
investigate the proximate-determinants of HIV
in female drug users. This study attempts to iden-
tify the risk factors associated with HIV infection
among incarcerated female drug users.
Methods
Study population and sampling procedure
HIV surveillance of Taiwan prison inmates was
officially established in 1990 as dictated by the
“AIDS Prevention and Control Act,” which was
amended in 2007 as the “HIV Infection Control
and Patient Rights Protection Act”.22 The Act 
requires mandatory HIV testing upon incarcera-
tion,22 with confirmation of their positive find-
ings through Western blot HIV testing. Prisoners
identified as HIV-positive are subsequently sepa-
rated from seronegative prisoners. Unlike many
other countries,20,21 Taiwan has never encoun-
tered an HIV infection outbreak in the prison
setting.
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In Taiwan, HIV testing occurs upon imprison-
ment to ensure the separate housing of infected
and uninfected inmates. This procedure made 
it possible for this study to enroll seropositive
participants without conducting independent
HIV testing. This study covers the period from
November to December, 2007. At that time, there
were 24 prisons in Taiwan, holding 3013 female
inmates, including 146 HIV-positive and 2867
HIV-negative female inmates.
In the first of two study stages, participants
completed a self-administered anonymous cen-
sus survey without providing any identifying in-
formation to the researcher. We recruited 2486
participants, including 139 HIV-positive and 2347
HIV-negative female inmates.18 In the second
stage, 114 of the 139 HIV-seropositive female in-
mates agreed to participate in the present survey,
achieving a response rate of 82%.
These 139 participants were assigned to the
Cases group for the Case-Control design adopted
in this study. In the same prison where the case
participants resided, we selected 2347 eligible
seronegative inmates from the census survey using
two criteria (“age ±3 years” and “had ever used any
illicit drugs”). Each eligible control candidate was
given a “random number” which was listed in se-
quential order. We then contacted the first eligible
control candidate. If she refused to participate, we
contacted the next one. All control subjects were
selected randomly with a match ratio of 2:1 to
ensure that the estimated control sample size
would be approximately 2 times that of the cases.
We proportionately selected control subjects until
we arrived at our estimated sample size, including
oversampling for non-participants. Consequently,
there were 278 eligible HIV-negative inmates con-
tacted, and 149 of them agreed to participate, for
a response rate of 54%.
Measures
The research instrument was a structured question-
naire focusing on three areas that might influence
HIV transmission risk: demographics and select
characteristics, behavioral factors prior to incarcer-
ation, and social factors prior to incarceration.
Demographic and select characteristics
Age, years of education, marital status, number of
children, employment status prior to incarcera-
tion, and other historical/demographic informa-
tion were collected. Other information gathered
included participants’ sexual orientation (hetero-
sexual, homosexual, bisexual), history of sexually
transmitted diseases in the past year, current crim-
inal charges, number or times imprisoned, prior
drug-related recidivism (a previous drug offense
convictions).
Pre-incarceration behavioral risk factors
The major behavioral risk factors for HIV infec-
tion were measured by two factors. The first was
drug-usage related risk, including drug-usage his-
tory regarding specific drug preferences, patterns
and mode of administration (such as if drugs were
smoked or injected) and experience sharing nee-
dles or dilutes. The second factor was sexual related
risk, including unsafe sexual behavior measured
by the frequency of condom use during the six
months prior to incarceration (never, seldom, half
of the time, most of the time, always).
Pre-incarceration social risk factors
Social risk factors were measured by several indica-
tor including: (1) having drug-using sexual partners
within six months prior to incarceration; (2) work-
ing in nightclubs or bars; (3) experience of physical
abuse; or (4) exchanging sex for money or drugs.
Statistical analyses
The data collected in this study was managed using
Microsoft Office Excel 2003, and analyzed using
SPSS software (version 14.0; SPSS Inc, Chicago IL,
USA). Continuous variables were described using
mean and standard deviation. Categorical variables
were presented as proportions. Univariate analysis,
Fisher’s exact test, and χ2 test for between-group
comparisons were applied where appropriate.
Age and years of education served as control vari-
ables in the multiple logistic regression analysis.
If two variables were thought to be highly corre-
lated to each other, then only one was included
in multivariate analysis. Selection of variables was
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based on the previous literature or those variables
with larger chi-square values. A p value of < 0.05
was considered statistically significant.
Results
Table 1 presents demographic data and other rel-
evant characteristics of participants. Participants
varied from age 18 to 51 years (mean = 32.0;
SD = 7.0). Only three participants were younger
than 20, and two older than 50. Over half (61.3%)
had completed at least 9 years of formal education.
A high percentage (77.8%) were never married,
divorced, separated, or widowed. About 41.1%
were unemployed prior to incarceration.
Most participants (91.0%) were incarcerated
on drug offenses, and 76.7% had previous drug-
related convictions. The case and control groups
differed significantly in years of formal educa-
tion, episodes of imprisonment, and drug-related
recidivism.
Table 2 displays the participants’ behavioral
and social risk factors related to HIV. Nearly 25.3%
Table 1. Demographic and select characteristics of participants
Variables HIV+ case (n = 114) Controls (n = 149) Total (n = 263) p
Age 0.19
≤ 30 56 (51.4) 65 (45.4) 121 (48.0)
31–40 42 (38.5) 52 (36.4) 94 (37.3)
≥ 41 11 (10.1) 26 (18.2) 37 (14.7)
Years of education < 0.05
≤ 9 78 (69.6) 80 (54.8) 158 (61.3)
≥ 10 34 (30.4) 66 (45.2) 100 (38.7)
Marital status 0.46
Never married 38 (34.2) 61 (41.8) 99 (38.5)
Divorced/separated/widowed 46 (41.4) 55 (37.7) 101 (39.3)
Married or cohabiting 27 (24.3) 30 (20.5) 57 (22.2)
Number of children 0.2
None 31 (27.2) 53 (35.6) 84 (31.9)
One or more 83 (72.8) 96 (64.4) 179 (68.1)
Working status prior to incarceration 0.08
Employed 59 (51.8) 93 (62.4) 152 (58.9)
Unemployed 55 (48.2) 56 (37.6) 106 (41.1)
Sex orientation 0.35
Heterosexual 101 (91.0) 126 (86.3) 227 (88.3)
Lesbian or bisexual 10 (9.0) 20 (13.7) 30 (11.7)
Current conviction 0.83
Drug offense 101 (91.0) 132 (91.0) 233 (91.0)
Others 10 (9.0) 13 (9.0) 23 (9.0)
Drug-related recidivism 93 (83.0) 105 (71.9) 198 (76.7) < 0.05
Number of times imprisoned < 0.001
1 (first time) 22 (19.6) 63 (43.5) 85 (33.1)
2–5 85 (75.9) 77 (53.1) 162 (63.0)
≥ 6 5 (4.5) 5 (3.4) 10 (3.9)
Had sexually transmitted diseases 13 (12.0) 27 (18.6) 40 (15.8) 0.21
in the past year
Data are presented as n (%). Missing data were excluded.
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of the participants in each group reported never
using condoms during penetrative intercourse.
More than half had worked at nightclubs or bars,
and over 70% in each group reported being phys-
ically abused by significant others. Roughly, 6.1%
reported exchanging sex for money or drugs be-
fore incarceration.
The most commonly used drugs were heroin
(71.9%), methamphetamine (25.4%), and mari-
juana (2.3%). Significant differences in inject-
able heroin use (p = 0.02) appeared between the
HIV infected (93.0%) and non-infected (84.6%)
groups. HIV-positive cases had a higher rate of
sharing drug paraphernalia than controls, partic-
ularly in sharing mainly dilutes (25.0% vs. 10.8%),
and sharing dilutes simultaneously with needles
(68.8% vs. 12.8%). Participants reported that their
experiences of “sharing dilutes only” included two
situations: “sharing dilutes only” or “sharing nee-
dles only.” Yet, those with “sharing needles only”
included only two participants in HIV+ groups,
and four in non-infected controls. Hence, these
two categories were combined into one category
in the analysis.
HIV-positive cases reported higher rates of hav-
ing drug-using sexual partners than control cases
(64.0% vs. 37.6%, p < 0.001). Among participants
with drug-using sexual partners (n = 129), the
HIV-positive cases had considerably higher rates
of sharing injection equipment with their sexual
partners than seronegative controls (98.6% vs.
32.1%, p < 0.001).
Table 3 shows multiple logistic regression an-
alyses of HIV infection risk. This data indicates
that repeated imprisonment of between 2–5 times
(OR = 5.23), sharing mainly dilutes only (OR =
63.47), and sharing dilutes simultaneously with
needles (OR = 127.33) predicted HIV serostatus
after controlling for age and years of education.
The mixture of sharing dilutes simultaneously
with needles increases the risk of contracting HIV.
Discussion
This study reveals several key findings. First, shar-
ing needles and/or dilutes with drug-using sexual
partners most strongly predicted HIV seropositivity.
Table 2. Behavioral and social risk factors of participants prior to incarceration
Variables
HIV+ case Controls Total 
p
(n = 114) (n = 149) (n = 263)
Behavioral factors
Had ever used any illicit drug 108 (94.7) 142 (95.3) 250 (95.1) 0.98
Had ever used injectable heroin 106 (93.0) 126 (84.6) 232 (88.2) 0.02
Sharing drug paraphernalia behavior < 0.001
No 7 (6.2) 113 (76.4) 120 (46.2)
Sharing mainly dilutes 28 (25.0) 16 (10.8) 44 (16.9)
Sharing dilutes and needles 77 (68.8) 19 (12.8) 96 (36.9)
Condom usage within six months prior 0.58
to incarceration
Never used condoms 31 (27.4) 35 (23.6) 66 (25.3)
Occasionally or often used condoms 82 (72.6) 113 (76.4) 195 (74.7)
Social factors
Ever worked in nightclubs or bars 63 (55.3) 78 (52.3) 141 (53.4) 0.73
Ever been physically abused by significant others 81 (73.0) 108 (75.5) 189 (74.4) 0.64
Ever exchange sex for money or drugs 8 (7.0) 8 (5.4) 16 (6.1) 0.76
Having drug-using sexual partners 73 (64.0) 56 (37.6) 129 (49.0) < 0.001
Had drug-using sexual partners as well as 72 (98.6) 18 (32.1) 90 (69.8) < 0.001
sharing drug paraphernalia (n = 129)
Data are presented as n (%). Missing data were excluded.
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Second, the number of imprisonments signifi-
cantly predicted HIV-infection risk. Third, condom
use was relatively infrequent in both groups.
Multiple logistic regression findings demon-
strate that HIV-infected female inmates were much
more likely to share needles and/or dilutes than
their non-infected counterparts, and particularly
those involved with drug-using sexual partners.
This finding suggests a complex interactive re-
lationship between sexual and drug-using part-
ners among female IDUs.12,23 Prior surveillance
research, e.g. Strathdee et al,24 showed marked
gender differences in the risk factors for HIV
seropositivity. Consistent with this literature, the
current study shows that women who had drug-
using sexual partners had over a 98% likelihood
of sharing needles or paraphernalia with their
sexual partners, thus greatly enhancing sexual
and injection risks for transmitting HIV.
HIV seropositivity and low educational attain-
ment significantly predicted episodes of recidi-
vism and imprisonment,25,26 which were relatively
high among study participants. Notably, signifi-
cantly more HIV+ cases (69.6%) than controls
(54.8%) failed to complete more than 9 years of
formal education. Education to 9 years is com-
pulsory in Taiwan. However, only 34.4% of
Taiwanese aged 15 years or over have failed to 
go beyond nine years of junior high school.27
Hence, our seropositive participants tended to not
exceed an educational level as those in the gen-
eral population.
Pre-incarceration, study participants reported
relatively infrequent use of condoms during pen-
etrative intercourse regardless of serostatus; specif-
ically, 27.4% of HIV-infected cases and 23.6% of
controls reported never using condoms. Several
factors may discourage safer sex practices in our
target population. Since seropositive individuals
frequently fail to disclose their HIV status,28 their
partners’ perception of self-risk might be unreal-
istically low. Because perceptions often influence
motivations and behaviors, our female partici-
pants might possess a false sense of safety, which
discourages condom use, especially with their pri-
mary sexual partner.10,29 In addition, women are
usually less empowered to influence condom use
and other safe sex decisions, given their frequent
economic dependence on their partners,30 and the
high percentage of reported physical abuse among
present study participants.
As suggested by participants’ infrequent con-
dom use, female drug users with incarceration
experience continue to represent a key “bridge”
population, transmitting HIV to their drug-using
partners and/or through commercial sex consu-
mers, and then in turn to the general population.
Thus, jails and prisons may present an ideal op-
portunity to conduct sexual education and drug
resistance programs in a population that would
otherwise be “hard to reach”. Mental health edu-
cation is an important factor for the incarcerated
population.19,31 Strengthening HIV/AIDS edu-
cation in jail settings may help reduce our high
observed recidivism rates, despite the fact that
there has been some level of education program-
ming officially been operating for many years 
in Taiwan.32
Table 3. Multiple logistic regression of factors
associated with HIV infection
Variable OR (95% CI) p
Age
≤ 30 1 (reference)
31–40 1.00 (0.44–2.30) 0.998
≥ 41 1.12 (0.30–4.12) 0.869
Years of education
≤ 9 1 (reference)
≥ 10 1.01 (0.44–2.31) 0.988
Number of 
times imprisoned
1 (first time) 1 (reference)
2–5 5.23 (1.97–13.91) 0.001
≥ 6 1.21 (0.22–6.60) 0.826
Sharing drug 
paraphernalia
No 1 (reference)
Sharing mainly 63.47 (17.49–230.32) 0.000
dilutes
Sharing dilutes 127.33 (37.36–433.98) 0.000
and needles
OR = odds ratio; CI = confidence interval.
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Limitations
The findings of this study are subject to several
limitations. First, the significance of our findings
is limited to the incarcerated female population,
and therefore lacks generalizability. Second, even
though 46% of enrolled HIV-negative controls did
not participate in this study, their ages were sim-
ilar to those of the cases. Since we did not collect
detailed demographic information, self-selection
bias might exist. Third, there was a wide range in
some variables in the 95% confidence intervals.
Although this is related to a small sample size in
this study, the findings must be interpreted with
caution. Finally, regardless of serostatus, the ex-
perience of trading sex for money or drugs (only
reported as 6%) may have been under-reported,
since most of our participants had worked in
nightclubs or bars.
In conclusion, the routes of HIV infection for
female drug users, including sharing needles and/
or dilutes, and practicing unsafe intercourse with
their drug-using sexual partners, places them at
considerable risk.
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